207 related articles for article (PubMed ID: 35377426)
21. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
[TBL] [Abstract][Full Text] [Related]
22. Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population.
Reid W; Broe G; Creasey H; Grayson D; McCusker E; Bennett H; Longley W; Sulway MR
Arch Neurol; 1996 Oct; 53(10):1056-61. PubMed ID: 8859068
[TBL] [Abstract][Full Text] [Related]
23. Sex Differences in Cognitive Abilities Among Children With the Autosomal Dominant Alzheimer Disease Presenilin 1 E280A Variant From a Colombian Cohort.
Fox-Fuller JT; Artola A; Chen K; Pulsifer M; Ramirez D; Londono N; Aguirre-Acevedo DC; Vila-Castelar C; Baena A; Martinez J; Arboleda-Velasquez JF; Langbaum JB; Tariot PN; Reiman EM; Lopera F; Quiroz YT
JAMA Netw Open; 2021 Aug; 4(8):e2121697. PubMed ID: 34463747
[TBL] [Abstract][Full Text] [Related]
24. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.
Willette AA; Bendlin BB; Starks EJ; Birdsill AC; Johnson SC; Christian BT; Okonkwo OC; La Rue A; Hermann BP; Koscik RL; Jonaitis EM; Sager MA; Asthana S
JAMA Neurol; 2015 Sep; 72(9):1013-20. PubMed ID: 26214150
[TBL] [Abstract][Full Text] [Related]
25. Understanding heterogeneity in older adults: Latent growth curve modeling of cognitive functioning.
MacAulay RK; Calamia MR; Cohen AS; Daigle K; Foil H; Brouillette R; Bruce-Keller AJ; Keller JN
J Clin Exp Neuropsychol; 2018 Apr; 40(3):292-302. PubMed ID: 28669314
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.
Ossenkoppele R; Lyoo CH; Jester-Broms J; Sudre CH; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; La Joie R; Rabinovici GD; Hansson O
JAMA Neurol; 2020 May; 77(5):632-642. PubMed ID: 32091549
[TBL] [Abstract][Full Text] [Related]
27. Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change.
Soldan A; Pettigrew C; Cai Q; Wang MC; Moghekar AR; O'Brien RJ; Selnes OA; Albert MS;
JAMA Neurol; 2016 Jun; 73(6):698-705. PubMed ID: 27064267
[TBL] [Abstract][Full Text] [Related]
28. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
[TBL] [Abstract][Full Text] [Related]
29. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
Wirth M; Villeneuve S; Haase CM; Madison CM; Oh H; Landau SM; Rabinovici GD; Jagust WJ
JAMA Neurol; 2013 Dec; 70(12):1512-9. PubMed ID: 24166579
[TBL] [Abstract][Full Text] [Related]
30. Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease.
Sano M; Raman R; Emond J; Thomas RG; Petersen R; Schneider LS; Aisen PS
Alzheimer Dis Assoc Disord; 2011; 25(2):122-7. PubMed ID: 20921876
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal Assessment of Physical Activity and Cognitive Outcomes Among Women at Midlife.
Greendale GA; Han W; Huang M; Upchurch DM; Karvonen-Gutierrez C; Avis NE; Karlamangla AS
JAMA Netw Open; 2021 Mar; 4(3):e213227. PubMed ID: 33787912
[TBL] [Abstract][Full Text] [Related]
32. Validation study of "Santé-Cerveau", a digital tool for early cognitive changes identification.
Lesoil C; Bombois S; Guinebretiere O; Houot M; Bahrami M; Levy M; Genthon R; Bozon F; Jean-Marie H; Epelbaum S; Foulon P; Villain N; Dubois B
Alzheimers Res Ther; 2023 Apr; 15(1):70. PubMed ID: 37013590
[TBL] [Abstract][Full Text] [Related]
33. Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial.
Vossel K; Ranasinghe KG; Beagle AJ; La A; Ah Pook K; Castro M; Mizuiri D; Honma SM; Venkateswaran N; Koestler M; Zhang W; Mucke L; Howell MJ; Possin KL; Kramer JH; Boxer AL; Miller BL; Nagarajan SS; Kirsch HE
JAMA Neurol; 2021 Nov; 78(11):1345-1354. PubMed ID: 34570177
[TBL] [Abstract][Full Text] [Related]
34. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM
J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769
[TBL] [Abstract][Full Text] [Related]
35. Early to Midlife Smoking Trajectories and Cognitive Function in Middle-Aged US Adults: the CARDIA Study.
Bahorik AL; Sidney S; Kramer-Feldman J; Jacobs DR; Mathew AR; Reis JP; Yaffe K
J Gen Intern Med; 2022 Apr; 37(5):1023-1030. PubMed ID: 33501538
[TBL] [Abstract][Full Text] [Related]
36. Age and cognitive decline in the UK Biobank.
Cornelis MC; Wang Y; Holland T; Agarwal P; Weintraub S; Morris MC
PLoS One; 2019; 14(3):e0213948. PubMed ID: 30883587
[TBL] [Abstract][Full Text] [Related]
37. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.
Mata IF; Leverenz JB; Weintraub D; Trojanowski JQ; Hurtig HI; Van Deerlin VM; Ritz B; Rausch R; Rhodes SL; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson AL; Espay AJ; Revilla FJ; Devoto J; Hu SC; Cholerton BA; Wan JY; Montine TJ; Edwards KL; Zabetian CP
JAMA Neurol; 2014 Nov; 71(11):1405-12. PubMed ID: 25178429
[TBL] [Abstract][Full Text] [Related]
38. Piloting and validation of a novel self-administered online cognitive screening tool in normal older persons: the Cognitive Function Test.
Trustram Eve C; de Jager CA
Int J Geriatr Psychiatry; 2014 Feb; 29(2):198-206. PubMed ID: 23754255
[TBL] [Abstract][Full Text] [Related]
39. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
Hohman TJ; Bell SP; Jefferson AL;
JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
[TBL] [Abstract][Full Text] [Related]
40. Specific Features of Executive Dysfunction in Alzheimer-Type Mild Dementia Based on Computerized Cambridge Neuropsychological Test Automated Battery (CANTAB) Test Results.
Kuzmickienė J; Kaubrys G
Med Sci Monit; 2016 Oct; 22():3605-3613. PubMed ID: 27717954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
